21 C.F.R. § 878.3500

Polytetrafluoroethylene with carbon fibers composite implant material

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

(a) Identification. A polytetrafluoroethylene with carbon fibers composite implant material is a porous device material intended to be implanted during surgery of the chin, jaw, nose, or bones or tissue near the eye or ear. The device material serves as a space-occupying substance and is shaped and formed by the surgeon to conform to the patient's need.

(b) Classification. Class II.

Notes of Decisions
Cited in 4 cases, 1993–1996 · leading case: Hoyt v. Vitek, Inc., 894 P.2d 1225 (Or. Ct. App. 1995).
Hoyt v. Vitek, Inc., 894 P.2d 1225 (Or. Ct. App. 1995). · cites it 2× “” 21 CFR § 878.3500 . That classification permits a device to be marketed under the “general controls” applicable to all devices — including registration, labeling, good manufacturing practices and compliance with misbranding provisions — until the FDA establishes specific…”
Lamontagne v. EI Du Pont De Nemours & Co., 834 F. Supp. 576 (D. Conn. 1993). “23872 (June 24, 1988); 21 C.F.R. § 878.3500 (1992). It is therefore clear that the FDA has established specific regulations with respect to Proplast implant material made with PTFE.”
Anguiano v. E.I. Du Pont de Nemours & Co., 44 F.3d 806 (9th Cir. 1995). “3695 , and PTFE with carbon fibers composite implant material, 21 C.F.R. § 878.3500 . 2 As identification provisions, these regulations do not “relate to the safety or effectiveness of the device,” 21 U.”
Kealoha v. E.I. du Pont de Nemours & Co., 82 F.3d 894 (9th Cir. 1996). “3695 , and PTFE with carbon fibers composite implant material, 21 C.F.R. § 878.3500 . As identification provisions, these regulations do not “relate to the safety or effectiveness of the device,” 21 U.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.